Jing Yang, PhD, Yabing Cao^*, Sungyongl Hong^*, Haiyan Li^*, Larry W. Kwak^* and Qing Yi^*

M.D. Anderson Cancer Center, Houston, TX

Yuko Hiruma, PhD, DDS^1*, Noriyoshi Kurihara, PhD, DDS^1*, Diane F. Jelinek, PhD² and David Roodman, MD, PhD¹

¹Medicine/Hem-Onc., University of Pittsburgh, Pittsburgh, PA
²Mayo Clinic/Foundation, Rochester, MN

Hai T. Ngo^1*, Evdoxia Hatjiharissi, MD¹, Alexey A. Leontovich, PhD^2*, Wee Chng, PhD^3*, Mena Farag^1*, Xavier Leleu, MD, PhD^1*, Xiaoying Jia^1*, Judith Runnels, PhD^1*, Aldo Roccaro, MD, PhD^1*, Abdel Kareem Azab, PhD^1*, Feda Azab^1*, Antonio Sacco^1*, Nicholas Burwick, MD^1*, Molly R. Melhem^1*, Kenneth C. Anderson, MD^1*, Rafael Fonseca, MD³, Thomas E. Witzig, MD^4* and Irene M. Ghobrial, MD^1*

¹Dana-Farber Cancer Institute, Boston, MA
²Mayo Clinic College of Medicine, Rochester, MN
³Mayo Clinic College of Medicine, Scottsdale, AZ
⁴Mayo Clinic, Rochester, MN

Sonia Vallet, MD^1*, Siddhartha Mukherjee, MD^2*, Nileshwari Vaghela, MS^1*, Samantha Pozzi, MD^3*, Loredana Santo, MD^3*, Diana Cirstea, MD^3*, Mariateresa Fulciniti, PhD^3*, Aliyah Rahemtullah, MD^4*, Eyal Attar, MD², Alexander R Guimaraes^5*, Wanling Xie^6*, Chirayu Patel^2*, Jesse Schoonmaker^2*, Edie Weller, PhD^6*, Teru Hideshima, M.D., Ph.D.³, Nikhil C. Munshi, MD³, Jas Seehra^7*, David T. Scadden, MD², Kenneth C Anderson, MD³ and Noopur Raje, MD^1*

¹Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
²Center for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA
³Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁴Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
⁵Center for Molecular Imaging Research and Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
⁶Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁷Acceleron Pharma, Inc, Cambridge, MA

Xin Li^1*, Wen Ling^1*, Angela Pennisi^1*, Jianmei Chen^1*, Sharmin Khan^1*, Mohammad Heidaran^2*, Herbert Faleck^2*, Robert Hariri^2*, John Shaughnessy^1*, Frits van Rhee^1*, Joshua Epstein^1*, Bart Barlogie^1* and Shmuel Yaccoby¹

¹Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR
²Celgene Inc, Warren, NJ

Judith Runnels, PhD^1*, Alicia Carlson, PhD^2*, Costas Pitsillides, PhD^2*, Joel Spencer, PhD^2*, Juwell Wu^2*, Abdel kareem Azab, PhD^1*, Aldo M. Roccaro, MD, PhD¹, Anne-Sophie Moreau, MD^1*, Xavier Leleu, MD, PhD^1*, Andrew Kung, MD, PhD³, Scott J. Rodig, MD, PhD^4*, Kenneth C Anderson, MD¹, Charles P. Lin, PhD^2* and Irene M. Ghobrial, M.D¹

¹Dana-Farber Cancer Institute, Boston, MA
²Advanced Microscopy Program, Center for Systems Biology and Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA
³Dana-Farber Cancer Inst., Boston, MA
⁴Department of Pathology, Brigham and Women Hospital, Boston, MA

Mala Mani, Ph.D.^1*, Jui Dutta^1*, Yunyu Zhang^1*, Daniel E Carrasco^1*, Yiming Zhou^2*, Moshe Gatt^1*, Bart Barlogie^2*, John D. Shaughnessy Jr., PhD³, Kenneth C Anderson, MD⁴ and Daniel Ruben Carrasco, M.D., Ph.D.^1*

¹Medical Oncology, Dana Farber Cancer Institute, Boston, MA
²Myeloma Institute for Research and Therapy, University of Arkansas for Medical Science, Little Rock, AR
³Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR
⁴Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA